33 related articles for article (PubMed ID: 17666845)
1. Effect of Cyclodextrin Types and Co-Solvent on Solubility of a Poorly Water Soluble Drug.
Charumanee S; Okonogi S; Sirithunyalug J; Wolschann P; Viernstein H
Sci Pharm; 2016 Oct; 84(4):694-704. PubMed ID: 27763573
[TBL] [Abstract][Full Text] [Related]
2. Estimation of drug precipitation upon dilution of pH-controlled formulations.
Narazaki R; Sanghvi R; Yalkowsky SH
Mol Pharm; 2007; 4(4):550-5. PubMed ID: 17530775
[TBL] [Abstract][Full Text] [Related]
3. Buffer capacity and precipitation control of pH solubilized phenytoin formulations.
Alvarez-Núñez FA; Yalkowsky SH
Int J Pharm; 1999 Aug; 185(1):45-9. PubMed ID: 10425364
[TBL] [Abstract][Full Text] [Related]
4. Solubilization behavior of a poorly soluble drug under combined use of surfactants and cosolvents.
Kawakami K; Oda N; Miyoshi K; Funaki T; Ida Y
Eur J Pharm Sci; 2006 May; 28(1-2):7-14. PubMed ID: 16406526
[TBL] [Abstract][Full Text] [Related]
5. High-throughput study of phenytoin solid dispersions: formulation using an automated solvent casting method, dissolution testing, and scaling-up.
Barillaro V; Pescarmona PP; Van Speybroeck M; Thi TD; Van Humbeeck J; Vermant J; Augustijns P; Martens JA; Van Den Mooter G
J Comb Chem; 2008; 10(5):637-43. PubMed ID: 18627202
[TBL] [Abstract][Full Text] [Related]
6. Miniature device for aqueous and non-aqueous solubility measurements during drug discovery.
Chen XQ; Venkatesh S
Pharm Res; 2004 Oct; 21(10):1758-61. PubMed ID: 15553219
[TBL] [Abstract][Full Text] [Related]
7. Estimation of drug precipitation upon dilution of pH-cosolvent solubilized formulations.
Narazaki R; Sanghvi R; Yalkowsky SH
Chem Pharm Bull (Tokyo); 2007 Aug; 55(8):1203-6. PubMed ID: 17666845
[TBL] [Abstract][Full Text] [Related]
8. In-vitro prediction of bioavailability following extravascular injection of poorly soluble drugs: an insight into clinical failure and the role of delivery systems.
Wu Z; Hassan D; Shaw JP
J Pharm Pharmacol; 2013 Oct; 65(10):1429-39. PubMed ID: 24028610
[TBL] [Abstract][Full Text] [Related]
9. Current perspectives of solubilization: potential for improved bioavailability.
Mallick S; Pattnaik S; Swain K; De PK
Drug Dev Ind Pharm; 2007 Aug; 33(8):865-73. PubMed ID: 17729104
[TBL] [Abstract][Full Text] [Related]
10. Review of the cosolvency models for predicting solubility of drugs in water-cosolvent mixtures.
Jouyban A
J Pharm Pharm Sci; 2008; 11(1):32-58. PubMed ID: 18445363
[TBL] [Abstract][Full Text] [Related]
11. Developing early formulations: practice and perspective.
Li P; Zhao L
Int J Pharm; 2007 Aug; 341(1-2):1-19. PubMed ID: 17658228
[TBL] [Abstract][Full Text] [Related]
12. Drug precipitation inhibitors in supersaturable formulations.
Xu S; Dai WG
Int J Pharm; 2013 Aug; 453(1):36-43. PubMed ID: 23680727
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
